mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.089 |
0.04 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
0.07 |
0.04 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.04 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.04 |
mRNA |
oligomycin a |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.04 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.065 |
0.04 |